COVID vaccine
University of Hong Kong, Sinopharm launch trial of Omicron-targeting vaccine
University of Hong Kong, Sinopharm launch trial of Omicron-targeting vaccine
A total of 1,800 adult volunteers will be needed for the trial.
Read Here
Advertise
Sign Up
Commentary
How commercial spaces must adapt to changing consumer expectations
AI, data centres, and the coming energy supercycle in Hong Kong
Reinsurance beyond borders: How Hong Kong can strengthen Asia’s risk-sharing architecture
Hong Kong hospitality insights: Robust investment, tourism expansion, and operational recovery
Hong Kong’s insurance boom is facing a financing test